Skip to main content
Panama Petrochem Ltd. logo

Panama Petrochem Ltd. — Investor Relations & Filings

Ticker · PANAMAPET ISIN · INE305C01029 LEI · 3358004XRSDP1JKD5I10 BSE.NS Manufacturing
Filings indexed 449 across all filing types
Latest filing 2022-05-30 Regulatory Filings
Country IN India
Listing BSE.NS PANAMAPET

About Panama Petrochem Ltd.

https://panamapetro.com

Panama Petrochem Ltd. is a manufacturer and exporter of petroleum specialty products, providing a diverse range of high-quality derivatives for global industrial applications. The company's core product portfolio includes liquid paraffin (white oil), petroleum jelly, transformer oil, and rubber process oil. Additionally, it produces industrial lubricants, greases, automotive oils, and specialized drilling fluids. These products serve critical sectors such as pharmaceuticals, cosmetics, power generation, rubber, and plastics. Operating advanced manufacturing facilities with integrated quality control laboratories, the company ensures adherence to international standards. Panama Petrochem focuses on technical excellence and the delivery of customized chemical solutions to meet the specific requirements of its international clientele.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings
2022-05-30 English
Financial Result Updates
Regulatory Filings
2022-05-30 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a formal communication from Panama Petrochem Ltd. to stock exchanges announcing an upcoming earnings conference call scheduled for May 31, 2022, to discuss financial results for the quarter and financial year ended March 31, 2022. It includes call details, participant information, and contact details. The document is short (2305 characters) and serves as an invitation or intimation rather than containing any financial data or results itself. Therefore, it is not the earnings release or the call transcript but an announcement about the earnings call event. According to the classification rules, such announcements are best classified as Regulatory Filings (RNS) since they do not fit other categories and are not the report or transcript itself.
2022-05-17 English
Address Change
Regulatory Filings Classification · 95% confidence The document is a short notice informing about a change in the corporate office address of the company's Registrar and Share Transfer Agent (RTA). It is addressed to stock exchanges and provides updated contact information. There is no financial data, no report attached or referenced, and no mention of voting results, management changes, or other regulatory filings beyond this address update. The document length is only 1320 characters, indicating it is a brief announcement. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-05-17 English
Board Meeting — Dividend/Financial results
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about an upcoming Board Meeting scheduled for May 30, 2022. The agenda includes approval of audited financial results for the quarter/year ended March 31, 2022, and recommendation of a final dividend. The document does not contain any financial data or results itself, but is an announcement of a meeting where such reports will be approved. The length is only 1396 characters, indicating it is a brief announcement rather than a full report. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement about a board meeting and upcoming financial results approval, not the results or reports themselves.
2022-05-17 English
General updates
Regulatory Filings Classification · 95% confidence The document is a confirmation certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialisation of securities for the quarter ended 31st March 2022. It is addressed to stock exchanges and references regulatory compliance rather than financial results or corporate governance changes. The document is short (3097 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of a report. It does not contain financial statements, management discussion, or shareholder meeting materials. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2022-04-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.